{"pmid":32450054,"title":"Hydroxychloroquine prophylaxis for high-risk COVID-19 contacts in India: a prudent approach.","text":["Hydroxychloroquine prophylaxis for high-risk COVID-19 contacts in India: a prudent approach.","Lancet Infect Dis","Tilangi, Praveen","Desai, Devashish","Khan, Adil","Soneja, Manish","32450054"],"journal":"Lancet Infect Dis","authors":["Tilangi, Praveen","Desai, Devashish","Khan, Adil","Soneja, Manish"],"date":"2020-05-26T11:00:00Z","year":2020,"_id":"32450054","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1016/S1473-3099(20)30430-8","locations":["India"],"countries":["India"],"countries_codes":["IND|India"],"topics":["Treatment"],"weight":1,"_version_":1667785213928800257,"score":9.490897,"similar":[{"pmid":32311324,"pmcid":"PMC7164849","title":"Hydroxychloroquine prophylaxis for COVID-19 contacts in India.","text":["Hydroxychloroquine prophylaxis for COVID-19 contacts in India.","Lancet Infect Dis","Rathi, Sahaj","Ish, Pranav","Kalantri, Ashwini","Kalantri, Shriprakash","32311324"],"journal":"Lancet Infect Dis","authors":["Rathi, Sahaj","Ish, Pranav","Kalantri, Ashwini","Kalantri, Shriprakash"],"date":"2020-04-21T11:00:00Z","year":2020,"_id":"32311324","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1016/S1473-3099(20)30313-3","locations":["India"],"countries":["India"],"countries_codes":["IND|India"],"e_drugs":["Hydroxychloroquine"],"topics":["Treatment"],"weight":1,"_version_":1666138491170324480,"score":71.55349},{"pmid":32348818,"pmcid":"PMC7195137","title":"Risks of Hydroxychloroquine use for COVID-19 prophylaxis.","text":["Risks of Hydroxychloroquine use for COVID-19 prophylaxis.","J Am Acad Dermatol","Sachdeva, Muskaan","Shah, Monica","Ziv, Michael","Leshem, Eyal","Dodiuk-Gad, Roni P","32348818"],"journal":"J Am Acad Dermatol","authors":["Sachdeva, Muskaan","Shah, Monica","Ziv, Michael","Leshem, Eyal","Dodiuk-Gad, Roni P"],"date":"2020-04-30T11:00:00Z","year":2020,"_id":"32348818","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1016/j.jaad.2020.04.111","keywords":["covid-19","evidence","hydroxychloroquine","overuse","prophylaxis","risks"],"locations":["Hydroxychloroquine"],"e_drugs":["Hydroxychloroquine"],"topics":["Treatment","Prevention"],"weight":1,"_version_":1666138495380357121,"score":46.567715},{"pmid":32348824,"pmcid":"PMC7195091","title":"Response to \"Risks of Hydroxychloroquine use for COVID-19 prophylaxis\".","text":["Response to \"Risks of Hydroxychloroquine use for COVID-19 prophylaxis\".","J Am Acad Dermatol","Grant-Kels, Jane M","32348824"],"journal":"J Am Acad Dermatol","authors":["Grant-Kels, Jane M"],"date":"2020-04-30T11:00:00Z","year":2020,"_id":"32348824","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1016/j.jaad.2020.04.112","e_drugs":["Hydroxychloroquine"],"topics":["Treatment","Prevention"],"weight":1,"_version_":1666138495383502848,"score":44.34124},{"pmid":32311322,"pmcid":"PMC7164862","title":"Chloroquine or hydroxychloroquine for prophylaxis of COVID-19.","text":["Chloroquine or hydroxychloroquine for prophylaxis of COVID-19.","Lancet Infect Dis","Principi, Nicola","Esposito, Susanna","32311322"],"journal":"Lancet Infect Dis","authors":["Principi, Nicola","Esposito, Susanna"],"date":"2020-04-21T11:00:00Z","year":2020,"_id":"32311322","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1016/S1473-3099(20)30296-6","e_drugs":["Hydroxychloroquine","Chloroquine"],"topics":["Treatment"],"weight":1,"_version_":1666138491166130176,"score":41.386333}]}